Innate immune dysregulation in multisystem inflammatory syndrome in children (MIS-C)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Innate immune dysregulation in multisystem inflammatory syndrome in children (MIS-C) ; volume:13 ; number:1 ; day:30 ; month:9 ; year:2023 ; pages:1-14 ; date:12.2023
Scientific reports ; 13, Heft 1 (30.9.2023), 1-14, 12.2023
- Urheber
-
Isaza-Correa, Johana
Ryan, Laura
Kelly, Lynne
Allen, John
Melo, Ashanty
Jones, Jennifer
Huggard, Dean
Ryan, Emer
Ó Maoldomhnaigh, Cilian
Geoghehan, Sarah
Gavin, Patrick
Leahy, Timothy Ronan
Butler, Karina
Freyne, Bridget
Molloy, Eleanor J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-43390-6
- URN
-
urn:nbn:de:101:1-2024020515510172755735
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Isaza-Correa, Johana
- Ryan, Laura
- Kelly, Lynne
- Allen, John
- Melo, Ashanty
- Jones, Jennifer
- Huggard, Dean
- Ryan, Emer
- Ó Maoldomhnaigh, Cilian
- Geoghehan, Sarah
- Gavin, Patrick
- Leahy, Timothy Ronan
- Butler, Karina
- Freyne, Bridget
- Molloy, Eleanor J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Multisystem inflammatory syndrome in children (MIS-C): a mini-review
Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID
Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population
Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: optimizing definition and management
Management of Multisystem Inflammatory Syndrome in Children (MIS-C) in resource limited settings: The Kenyan Experience
Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) in a Middle Eastern patient cohort
Multisystem inflammatory syndrome in children (MIS-C) post-COVID-19 in Iran: clinical profile, cardiac features, and outcomes
Multisystem inflammatory syndrome in children (MIS-C) and sepsis differentiation by a clinical and analytical score: MISSEP score
First diagnosis of multisystem inflammatory syndrome in children (MIS-C): an analysis of PoCUS findings in the ED
Longitudinal Cardiac Evaluation of Children with Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 by Conventional and Speckle-Tracking Echocardiography
Combined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric cases
The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis
Multisystem inflammatory syndrome in children (MIS-C): a mini-review
Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID
Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population
Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: optimizing definition and management
Management of Multisystem Inflammatory Syndrome in Children (MIS-C) in resource limited settings: The Kenyan Experience
Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) in a Middle Eastern patient cohort
Multisystem inflammatory syndrome in children (MIS-C) post-COVID-19 in Iran: clinical profile, cardiac features, and outcomes
Multisystem inflammatory syndrome in children (MIS-C) and sepsis differentiation by a clinical and analytical score: MISSEP score
First diagnosis of multisystem inflammatory syndrome in children (MIS-C): an analysis of PoCUS findings in the ED
Longitudinal Cardiac Evaluation of Children with Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 by Conventional and Speckle-Tracking Echocardiography
Combined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric cases
The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis
Multisystem inflammatory syndrome in children (MIS-C): a mini-review
Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID
Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population
Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: optimizing definition and management
Management of Multisystem Inflammatory Syndrome in Children (MIS-C) in resource limited settings: The Kenyan Experience
Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) in a Middle Eastern patient cohort
Multisystem inflammatory syndrome in children (MIS-C) post-COVID-19 in Iran: clinical profile, cardiac features, and outcomes
Multisystem inflammatory syndrome in children (MIS-C) and sepsis differentiation by a clinical and analytical score: MISSEP score
First diagnosis of multisystem inflammatory syndrome in children (MIS-C): an analysis of PoCUS findings in the ED
Longitudinal Cardiac Evaluation of Children with Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 by Conventional and Speckle-Tracking Echocardiography
Combined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric cases